MUDr. Alena Vachova
- Address
- lock Available on a paid plan
Cardiovascular Disease Research
At MUDr. Alena Vachova in Ceske Budejovice, clinical research is focused on Cardiovascular Diseases, with studies centered on serious heart and blood vessel conditions. The main disease areas include Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus, reflecting a strong interest in reducing major cardiovascular risk.
- Evaluating a new therapy aimed at lowering the risk of major heart, stroke, and vascular events
- Comparing treatment approaches for people with diabetes and high cardiovascular risk
This research is designed to improve treatment effectiveness and help prevent life-threatening outcomes such as heart attack, stroke, and other vascular complications.
Metabolic and Cardiovascular Outcomes
The site also contributes to research linking Type 2 Diabetes Mellitus with cardiovascular complications, an important area where metabolic and heart health overlap. These trials look at whether newer treatment options can better protect patients already receiving standard care.
- Testing whether a novel glucose-lowering therapy can match or outperform an established comparator for cardiovascular protection
- Studying major adverse cardiovascular events in patients with diabetes and elevated risk
Overall, the clinical work here aims to support safer and more effective care for patients facing both diabetes and cardiovascular disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Eli Lilly & Co.1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Eli Lilly & Co.3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in MUDr. Alena Vachova
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Effect of Orforglipron on Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease | Eli Lilly & Co. | Phase III | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cagrilintide | 1 | Unknown | 2025-10-31 | 2025-10-31 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.